USP18 downregulation in peripheral blood mononuclear cells predicts nonresponse to interferon-based triple therapy in patients with chronic hepatitis C, genotype 1: a pilot study. [electronic resource]
- Therapeutics and clinical risk management 2015
- 1853-61 p. digital